Localized Oral Mucous Membrane Pemphigoid: Successful Treatment with Intralesional Triamcinolone Acetonide Injection
Elif PEKER1, Güzin Neda HASANOGLU ERBASAR2*, Burcu SENGÜVEN3
Affiliation
- 1Gazi University, Faculty of Dentistry, Department of Oral and Maxillofacial Surgery, Ankara, Turkey
- 2Yıldırım Beyazıt University, Faculty of Dentistry, Department of Oral and Maxillofacial Surgery, Ankara, Turkey
- Gazi University, Faculty of Dentistry, Department of Oral Pathology, Ankara, Turkey
Corresponding Author
Guzin Neda Hasanoslu Erbasar, Dögol Caddesi. MEB Kampüsü H Blok 06560 Besevler-Ankara-Türkiye, Tel: 0090 555 526 67 51; Fax: 0090 312 2151930; E-mail: neda986@gmail.com
Citation
Hasanoglu Erbasar, N.G., et al. Localized Oral Mucous Membrane Pemphigoid: Successful Treatment with Intralesional Triamcinolone Acetonide Injection. (2016) J Dent Oral Care 2(5): 1- 5.
Copy rights
© 2016 Hasanoslu Erbasar, N.G. This is an Open access article distributed under the terms of Creative Commons Attribution 4.0 International License.
Keywords
Abstract
Mucous membrane pemphigoid (MMP) is a rare, chronic and vesiculobullous disorder that classified as autoimmune disease.MMP can affect various mucous membranes but predominantly occurs in the oral cavity. In most of cases oral lesions may be initial manifestation or the only sign of the disease. It is predominantly seen in the fifth decade of life. It affects women more commonly than men. Children are rarely affected from this disease. MMP may cause extremely variable severity due to different clinical presentations as vesicles, erosions, pain, and occasional scarring. Oral lesions as gingival inflammation and scarring are not life theatening but lead to functional limitations. The primary goals of the treatment are to cease the progression of the disease, reduce the symptoms, and prevent the sequelae of tissue ulseration and consecutive scarring. The mild MMP lesions may be successfully managed with topical corticosteroids. However, the lesions that do not respond to local treatments or become widespread and also the diseases which show rapid progress can be treated can be treated with systemic glucocorticoids and immunosuppressive agents such as azathioprine, mycophenolatemofetyl, cyclosporine, and dapsone, rituximab and intravenous immunoglobulin. In this report two cases of oral MMP treated successfully with intralesional triamcinolone acetonide are presented along with a review of literature.
